Kim Davis focuses her practice on prosecuting foreign and domestic patent applications in pharmaceuticals, polymers, the chemical arts, materials, and metallurgy, due diligence and freedom to operate analysis, and client counseling and portfolio strategy for companies, universities and research institutions.
With a background in organic and medicinal chemistry, Dr. Davis has pursued a career supporting life science innovators in all of their patent needs, including strategic patent counseling, portfolio development, and prosecution services.
Dr. Davis provides litigation support in an array of technologies, including pharmaceuticals, polymers, drug and chemical formulations, and drug delivery systems. In particular, she has extensive experience in preparing non-infringement and invalidity opinions and in performing freedom-to-operate analyses and due diligence for pharmaceutical and chemical clients.
While attending graduate school, she designed and synthesized nucleoside analogues as HIV-1 reverse transcriptase inhibitors and also focused on developing methodology to improve the regioselectivity of nucleoside base couplings under advisor Dr. Dennis Liotta. Dr. Davis also served as an intern in the Emory University Office of Technology Transfer, where she assessed the marketability and patentability of technologies. While attending Xavier University of Louisiana, Dr. Davis worked as a summer intern in medicinal chemistry at Eli Lilly and Company.
Dr. Davis has co-authored scientific and legal journal manuscripts and presented at several scientific meetings. She is a recipient of Apex Society’s Power 30 Under 30™ Award, was recognized as a Superwoman of the Future by Atlanta Tribune Magazine, and has been profiled by Rolling Out Atlanta Magazine. During law school, Dr. Davis received the GSU College of Law Intellectual Property Scholarship and served as a graduate research assistant for the GSU Intellectual Property Advisory Board.
Dr. Davis was recognized in 2018, 2019 and 2021 as a Georgia "Rising Star" in the area of Intellectual Property by Super Lawyers magazine. She was recognized in 2022 as one of the "Best Lawyers: Ones to Watch" for Patent Law by The Best Lawyers in America®. Dr. Davis is a recipient of the National Bar Association’s “40 Under 40 Nation’s Best Advocates” Award in 2021 and was named a 2021 Georgia Legal Award honoree as an attorney “On the Rise” by The Daily Report. She was also named a “40 Under 40 Leader” by Emory University Alumni Association in 2020. Dr. Davis serves as the co-chair of KT Voice, Kilpatrick's resource group focused on promoting the interests of Black attorneys.
Insights View All
Georgia State University, College of Law J.D. (2013) magna cum laude
Emory University Ph.D. (2008) Organic Chemistry
Xavier University of Louisiana B.S. (2004) Biochemistry, summa cum laude
U.S. Patent and Trademark Office (2009)
Atlanta Broadening Experiences in Scientific Training (BEST) Program, Emory University and Georgia Institute of Technology, Advisory Committee (2015-2016)
American Chemical Society, Member
Atlanta Intellectual Property Inn of Court, Member (2015-2018)
Georgia Association of Black Women Attorneys, Member
Georgia State University College of Law, Intellectual Property Advisory Board Member (2014-2016)
Jumpstart Atlanta, Advisory Board, Co-Chair (2016-Present)
Jumpstart, National Board of Directors, Member (2018-Present)
MEMO|Medicine & Molecules, The Kilpatrick Townsend Biopharma Industry Blog, Co-Editor-in-Chief
National Bar Association, Member
Superintendent's Advisory Council, Fayette County, Member (2019-Present)
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.